Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients

Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients

The present study sought to investigate the genetic variants in drug metabolizing enzyme and transporter (DMET) genes associated with steady-state plasma concentrations of risperidone among Thai autism spectrum disorder (ASD) patients. ASD patients taking risperidone for at least one month were enro...

Full description

Bibliographic Details
Main Authors:	Sadeep Medhasi, Darawan Pinthong, Ekawat Pasomsub, Natchaya Vanwong, Nattawat Ngamsamut, Apichaya Puangpetch, Monpat Chamnanphon, Yaowaluck Hongkaew, Jirawat Pratoomwun, Penkhae Limsila, Chonlaphat Sukasem
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-12-01
Series:	Frontiers in Pharmacology
Subjects:	Risperidone pharmacogenomics transporters Autism Spectrum Disorders drug metabolizing enzymes
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00475/full

Similar Items

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors
by: Natchaya Vanwong, et al.
Published: (2020-11-01)

Associations of the <i>SREBF2</i> Gene and <i>INSIG2</i> Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone
by: Natchaya Vanwong, et al.
Published: (2021-09-01)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
by: Yaowaluck Hongkaew, et al.
Published: (2021-10-01)

CYP2D6 polymorphisms and their influence on risperidone treatment
by: Puangpetch A, et al.
Published: (2016-12-01)

Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients
by: Chalirmporn Atasilp, et al.
Published: (2022-07-01)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022-05-01)

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
by: Mohitosh Biswas, et al.
Published: (2024-02-01)

Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
by: Chalirmporn Atasilp, et al.
Published: (2022-07-01)

HLA-B*58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand
by: Chonlaphat Sukasem, et al.
Published: (2016-07-01)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
by: Napatrupron Koomdee, et al.
Published: (2017-11-01)

Effect of ABCB1 3435C>T transporter gene polymorphism on plasma efavirenz concentration in HIV-1 infected Thai adults
by: Sahapat Barusrux, et al.
Published: (2020-01-01)

A Review: Antimicrobial Therapy for Human Pythiosis
by: Sadeep Medhasi, et al.
Published: (2022-03-01)

Ex vivo observation of Pythium insidiosum-antigen treated neutrophils on three Pythium insidiosum strains isolated from vascular pythiosis patients
by: Sadeep Medhasi, et al.
Published: (2024-12-01)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study.
by: Asita Wongprikorn, et al.
Published: (2016-01-01)

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
by: Kanyarat Khaeso, et al.
Published: (2021-12-01)

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
by: Patompong Satapornpong, et al.
Published: (2020-02-01)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
by: Napatrupron Koomdee, et al.
Published: (2022-04-01)

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
by: Jirawat Pratoomwun, et al.
Published: (2021-04-01)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
by: Chamnanphon M, et al.
Published: (2020-01-01)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022-04-01)

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
by: Rattanaporn Sukprasong, et al.
Published: (2021-06-01)

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors
by: Sukasem C, et al.
Published: (2013-08-01)

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity
by: CHONLAPHAT eSUKASEM
Published: (2015-01-01)

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
by: Teerapat Majam, et al.
Published: (2023-11-01)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
by: Ai-Hoc Nguyen, et al.
Published: (2023-07-01)

Effect of <i>GSTA1</i> Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians
by: Ai-Hoc Nguyen, et al.
Published: (2022-02-01)

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report
by: Tan-kam T, et al.
Published: (2013-01-01)

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
by: Mohitosh Biswas, et al.
Published: (2022-02-01)

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand
by: Bushyakanist A, et al.
Published: (2015-11-01)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
by: Kanyawan Tiwattanon, et al.
Published: (2022-07-01)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023-03-01)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01)

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions.
by: Kanoot Jaruthamsophon, et al.
Published: (2016-01-01)

Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen
by: Chamnanphon M, et al.
Published: (2013-05-01)

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
by: Chalitpon Na nakorn, et al.
Published: (2020-06-01)

Pemphigus – A clinical study with clinico-immuno-histopathologic correlation
by: P N Mini, et al.
Published: (2019-01-01)

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia
by: Puangpetch A, et al.
Published: (2019-08-01)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
by: Mohitosh Biswas, et al.
Published: (2022-08-01)

Simplified and Rapid Determination of Primaquine and 5,6-Orthoquinone Primaquine by UHPLC-MS/MS: Its Application to a Pharmacokinetic Study
by: Waritda Pookmanee, et al.
Published: (2021-07-01)

A Comprehensive Review of <i>HLA</i> and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
by: Chiraphat Kloypan, et al.
Published: (2021-10-01)